Share ownership Johnson & Johnson

JNJ

US4781601046

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:02 2026-01-21 pm EST			5-day change	1st Jan Change
218.01 ^USD	-0.09%		-0.25%	+5.34%

Jan. 21	Health Care Up After Trump Rescinds Tariff Threats - Health Care Roundup	DJ
Jan. 21	Sector Update: Health Care Stocks Higher Late Afternoon	MT

Share class: Johnson & Johnson

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	3,120,537,693	2,405,417,695 ( 77.08 %)	712,921,000 ( 22.85 %)	77.08 %

Major shareholders: Johnson & Johnson

Name	Equities	%	Valuation
Vanguard Fiduciary Trust Co. 9.821 %	236,618,586	9.821 %	48 968 M $
BlackRock Advisors LLC 6.4 %	154,197,786	6.4 %	31 911 M $
STATE STREET CORPORATION 5.487 %	132,206,061	5.487 %	27 360 M $
JPMorgan Investment Management, Inc. 2.437 %	58,722,055	2.437 %	12 153 M $
Geode Capital Management LLC 2.333 %	56,215,455	2.333 %	11 634 M $
Eaton Vance Management 2.002 %	48,231,667	2.002 %	9 982 M $
BlackRock Life Ltd. 1.96 %	47,210,359	1.96 %	9 770 M $
Norges Bank (13F) 1.325 %	31,929,124	1.325 %	6 608 M $
State Farm Investment Management Corp. 1.311 %	31,590,952	1.311 %	6 538 M $
Merrill Lynch International 1.18 %	28,419,787	1.18 %	5 881 M $
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
Itaú Unibanco Asset Management Ltda. 0.00051 %	184,357	0.00051 %	3 M $
Morgan Stanley Administradora de Carteiras SA 0 %	51	0 %	702 $

Breakdown by shareholder type

Institutional	57.03%
Other	8.09%
State Street Corp.	5.49%
Schweizerische Nationalbank	0.29%
Sumitomo Mitsui Trust Group, Inc.	0.26%
Governments	0.16%
Manulife Financial Corp.	0.15%
Swedbank AB	0.09%
Danske Bank A/S	0.08%
SEI Investments Co.	0.08%
The Bank of Nova Scotia	0.07%
Fifth Third Bancorp	0.05%
ING Groep NV	0.04%
Regions Financial Corp.	0.04%
Commerzbank AG	0.04%
Individuals	0.04%
Markel Group, Inc.	0.03%
Silvercrest Asset Management Group, Inc.	0.03%
First Financial Bankshares, Inc.	0.03%
Rathbones Group Plc	0.03%
Skandinaviska Enskilda Banken AB	0.03%
Zurich Insurance Group AG	0.02%
Peapack-Gladstone Financial Corp.	0.02%
Banco Bilbao Vizcaya Argentaria SA	0.01%
Hikari Tsushin, Inc.	0.01%
First Horizon Corp. (Tennessee)	0.01%
Associated Banc-Corp	0.01%
Cincinnati Financial Corp.	0.01%
Hancock Whitney Corp.	0.01%
Cullen/Frost Bankers, Inc.	0.01%
Old Republic International Corp.	0.01%
Unknown	27.73%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	53.97%
United Kingdom	7.51%
Canada	2.92%
Norway	1.44%
Australia	0.9%
France	0.85%
Japan	0.76%
Germany	0.69%
Switzerland	0.6%
Sweden	0.55%
Hong Kong	0.41%
Denmark	0.36%
South Korea	0.27%
Ireland	0.19%
Netherlands	0.18%
Luxembourg	0.13%
Belgium	0.1%
Italy	0.09%
Finland	0.07%
Individuals	0.04%
Spain	0.04%
Czech Republic	0.03%
Portugal	0.03%
Austria	0.03%
Singapore	0.02%
Liechtenstein	0.02%
South Africa	0.02%
Brazil	0.01%
New Zealand	0.01%
Saudi Arabia	0.01%
China	0.01%
Slovenia	0.01%

Based on 1000 largest holdings

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (64.1%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (35.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; At the end of 2024, Johnson & Johnson has 64 manufacturing facilities located in the United States (23), North America (7), Europe (21), Africa and Asia/Pacific (13). The United States accounts for 56.6% of net sales.

Employees

138,100

Sector

Pharmaceuticals

Calendar

Feb. 23 - Ex-dividend day

More about the company